Moreover, oral semaglutide has been proved non-inferior to placebo in terms of CV safety [21], providing a new choice for the management of T2D and a convenient administration route for patients who prefer oral treatments over injectable therapies
Polycythemia Vera: Use with caution as vitamin B12 may increase red blood cell production
2011;22(5):91426 Kim AJ, Lim HJ, Ro H, Ko KP, Han SY, Chang JH,
Quick Answer: Dulaglutide and once-weekly exenatide appear to have the lowest rates of nausea amongst GLP-1 receptor agonists, with approximately 1224% of patients affected compared with higher rates seen with other formulations
GLP-1 related dry mouth often persists regardless of fluid intake because the underlying cause involves changes in saliva production or composition, not just total body hydration